Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma
Antibody mediated strategies for protein biomarker detection are common, but may limit discovery. We hypothesized that the use of antibody-free proteomics is feasible for detecting protein biomarkers in plasma of patients sustaining major trauma. A subset of subjects with major trauma from a prospec...
Format: | Article |
---|---|
Language: | English |
Published: |
Mary Ann Liebert
2021-07-01
|
Series: | Neurotrauma Reports |
Online Access: | https://www.liebertpub.com/doi/full/10.1089/NEUR.2021.0007 |
Similar Items
-
Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry.
by: Heping Cao, et al.
Published: (2014-01-01) -
Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of Urinary Identification in Diabetic Vascular Dementia in a Han Chinese Population
by: Ruijuan Chen, et al.
Published: (2021-02-01) -
Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry
by: Pauline eBros, et al.
Published: (2015-09-01) -
Direct Identification of Functional Amyloid Proteins by Label-Free Quantitative Mass Spectrometry
by: Heidi N. Danielsen, et al.
Published: (2017-08-01) -
Using mass spectrometry for investigating cancer detection markers and quantifying therapeutic monoclonal antibodies in human plasma
by: Huai-Hsuan Chiu, et al.
Published: (2018)